Similar articles

• [Alpha beta-blockers for patients with hypertension].

  Mizuta Y, Imaizumi T. Mizuta Y, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:305-9. Nihon Rinsho. 2006. PMID: 16981560 Review. Japanese. No abstract available.
• Current status of labetalol, the first alpha- and beta-blocking agent.

  Kanto JH. Kanto JH. Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):617-28. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 2867049 Review.
• Carvedilol.

  Frishman WH. Frishman WH. N Engl J Med. 1998 Dec 10;339(24):1759-65. doi: 10.1056/NEJM199812103392407. N Engl J Med. 1998. PMID: 9845712 Review. No abstract available.
• [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].

  Rossano P, Saffiotti O, Mayer MC, Blasich M, Rossano G, Bellotti P. Rossano P, et al. Minerva Cardioangiol. 1980 May;28(5):309-14. Minerva Cardioangiol. 1980. PMID: 6111048 Italian. No abstract available.
• [Control of blood pressure in prevention of hypertensive end-organ damage].

  Kido M, Ando K, Fujita T. Kido M, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:389-93. Nihon Rinsho. 2004. PMID: 15171405 Review. Japanese. No abstract available.